| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K07442505 |
| PharmacoGx | BRD-K07442505 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAB3D | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | CFL1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | ZNF696 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | VSTM2L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PPP1R37 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PSMD1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CPS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | NUP35 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | FAM63B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | DHCR24 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
